Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Condylomata Acuminata 1Cancer Survivor 1

Interventions

Gels 3hecolin 1berdazimer sodium 1Vaccines, Synthetic 1Vaccines 1VP-102 1Therapies, Investigational 1Podophyllin 1Papillomavirus Vaccines 1Omiganan 1Imiquimod 1Human Papillomavirus Recombinant Vaccine nonavalent 1Cryotherapy 1Cantharidin 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Condylomata Acuminata × Vaccines, Synthetic × Clear all
NCT00551187 2015-06-08

A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)

Merck Sharp & Dohme LLC

Phase 2 Completed
620 enrolled
Gynecologic

Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡